Company intelligence / Profile preview

HyliDx

Ottawa, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

HyliDx has developed a lab-equivalent, internet-connected home blood-testing system for potassium; prototype is clinically validated for rapid, accurate monitoring in chronic disease. Clinical results not yet published but the product is aimed to fill a critical unmet need for home potassium measurement, especially in advanced CKD and heart failure, to prevent life-threatening complications and reduce hospitalizations.

Therapeutic areas: NephrologyCardiovascular
Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

Capital BioVentures

Beyond the preview

Go deeper on HyliDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HyliDx.

Explore the full profile